USPTO 2015–2025 USPTO PatentsView US Corporation

Merck Sharp & Dohme LLC

USPTO PatentsView assignee record — 1,248 granted patents across 66 technology areas, active 2015–2025. Filing-trend and competitive-moat analysis cross-referenced to USPTO Patent Public Search. Primary class: A61P (SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS).

1,248
Total patents granted
66
CPC technology areas
15.3
Avg claims per patent
-43%
5-year filing velocity

Portfolio overview

Merck Sharp & Dohme LLC has been granted 1,248 US utility patents between 2015 and 2025, placing Merck Sharp & Dohme LLC at rank #344 across all assignees tracked by PlainPatent. This portfolio spans 66 distinct Cooperative Patent Classification (CPC) subclasses, averaging 15.3 claims per patent with primary concentration in A61P (SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS). As a US Corporation, Merck Sharp & Dohme LLC is one of the broader-portfolio assignees in the PatentsView dataset. The composite Innovation Score of 62.6/100 blends portfolio volume, filing velocity, technology breadth, and claim depth into a single comparable measure drawn directly from USPTO PatentsView records.

Filing cadence tells the strategic story. Between 2020 and 2025 the company received 454 grants, compared with 794 in the 2015–2019 window — a -43% shift in five-year velocity. A cooling filing rate may reflect portfolio consolidation, shifting priorities, or reduced R&D throughput. The US Corporation classification further shapes interpretation, since corporate, government, and individual filers pursue patents for materially different reasons.

Claim depth and technology breadth together indicate competitive posture. Merck Sharp & Dohme LLC's 15.3 average claims per patent sits within the typical range for solid legal coverage without excessive prosecution cost, while a multi-domain presence across 66 subclasses balances depth with breadth. Combined with portfolio volume, these signals let analysts, investors, and licensing professionals benchmark Merck Sharp & Dohme LLC against peers pursuing similar technology classes.

How does Merck compare?

Granted US patents 2015–2025 versus the largest corporate holders — this company marked ◀

patents

What this shows Merck holds 1,248 patents — placing it at rank #344 overall, well behind the volume leaders but ahead of the tens of thousands of smaller assignees in the dataset.

Source USPTO PatentsView — granted utility patents As of 2015–2025

USPTO utility patent grants by year · 2015–2025

050100150200 20152016201720182019202020212022202320242025 58
USPTO utility patent grants by year · 2015–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.

View data table
Merck Sharp & Dohme LLC patent grants by year, 2015–2025
Year Patents Granted Share of Period
2015 153 12.3%
2016 173 13.9%
2017 188 15.1%
2018 151 12.1%
2019 129 10.3%
2020 103 8.3%
2021 102 8.2%
2022 71 5.7%
2023 51 4.1%
2024 69 5.5%
2025 58 4.6%

Which technologies does Merck Sharp & Dohme LLC patent most?

Top 15 of 66 technology areas

Patent Moat Analysis

Portfolio Volume Strong
Tech Breadth Multi-domain
Claim Depth Standard
Velocity Declining

Where it ranks

Overall rank by patents

#344

Across all tracked assignees

Innovation Score

62.6 out of 100

View all rankings →

Data Source

USPTO PatentsView — US granted patents 2015–2025

How is Innovation Score calculated?

Frequently Asked Questions

How many patents does Merck Sharp & Dohme LLC hold?
Merck Sharp & Dohme LLC holds 1,248 US granted patents filed between 2015 and 2025, spanning 66 technology areas.
What is Merck Sharp & Dohme LLC's Innovation Score?
Merck Sharp & Dohme LLC has an Innovation Score of 62.6 out of 100. This composite metric weighs portfolio volume (40%), filing velocity (20%), technology breadth (25%), and claim depth (15%).
What technology areas does Merck Sharp & Dohme LLC focus on?
Merck Sharp & Dohme LLC's top technology area is A61P (SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS) with 889 patents. The company has filed patents in 66 CPC subclasses total.
Is Merck Sharp & Dohme LLC's patent filing rate increasing or decreasing?
Merck Sharp & Dohme LLC's recent filing velocity is -43% compared to the prior five-year period. Filing activity has slowed relative to earlier years.
What does claim depth mean for Merck Sharp & Dohme LLC's patents?
Merck Sharp & Dohme LLC's patents average 15.3 claims each. This falls within the standard range, providing solid legal coverage.
How is the Merck Sharp & Dohme LLC patent data sourced?
All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

Learn More

Explore the patent dataset

Data sourced from USPTO PatentsView — official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent Editorial

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

All federal data sources used on this page
  • USPTO PatentsView — official U.S. Patent and Trademark Office bulk patent data. patentsview.org
  • USPTO Patent Application Information Retrieval (PAIR) — application status and file history. uspto.gov/patents/pair
  • USPTO Bulk Data Storage System — comprehensive patent text + claims dataset. bulkdata.uspto.gov
  • USPTO CPC Classification — Cooperative Patent Classification scheme for technology categorization. uspto.gov/cpc
  • SEC EDGAR — public filings cross-reference for assignee corporate entity matching. sec.gov/edgar
  • WIPO PATENTSCOPE — international patent context (related international filings). wipo.int/patentscope